DarioHealth Doubles Hypertension Reach in Solera Network, Hitting 500K Eligible Lives

Event summary

  • DarioHealth expanded its hypertension program within Solera Health's network, doubling its addressable market.
  • The program now covers pre-hypertensive to Stage 2 hypertension, reaching over 500,000 eligible lives.
  • Revenue is tied directly to engagement and clinical outcomes, enhancing long-term value creation.
  • Dario's AI-driven engagement engine and personalized coaching support sustained behavior change.
  • The expansion leverages Solera's established payer and employer relationships for scalable growth.

The big picture

DarioHealth's expansion into hypertension within Solera Health's network addresses one of the largest unmet needs in healthcare, affecting nearly half of U.S. adults. This move aligns with the broader industry trend toward value-based care, where outcomes and engagement drive revenue. The partnership underscores Dario's position as a key player in digital health, particularly in managing chronic conditions through scalable, data-driven solutions.

What we're watching

Market Penetration
How DarioHealth will leverage Solera's network to expand into non-diabetic hypertension populations.
Revenue Predictability
Whether tying revenue to longitudinal outcomes will strengthen Dario's financial stability.
Scalability
The pace at which Dario can integrate and scale additional cardiometabolic programs within Solera's network.

Related topics

Technology